Teladoc Chief Legal Officer Adam Vandervoort resigns effective Nov 1, 2026; Jonathan Dorfman named successor

Teladoc Health, Inc.

Adam C. Vandervoort, Chief Legal Officer and Secretary, informed Teladoc on September 24, 2026 he will resign effective November 1, 2026.
Resignation was made 'with good reason' under his executive severance agreement, implying a constructive-termination claim.
Jonathan Dorfman, currently SVP, Securities & Corporate Law, will assume the Chief Legal Officer and Secretary role.
Vandervoort will provide transition advisory services until November 1, 2027 and will receive no compensation for them.
Filing signed by Vandervoort as Chief Legal Officer on September 25, 2026; no other officer or director changes disclosed.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.